These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23562050)

  • 41. Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice.
    Gotsman I; Israeli D; Alper R; Rabbani E; Engelhardt D; Ilan Y
    Int J Cancer; 2002 Jan; 97(1):52-7. PubMed ID: 11774243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GB virus C/hepatitis G virus infection among patients with hepatocellular carcinoma in the inshore area of the Yangtze River, China.
    Cao K; Mizokami M; Orito E; Ding X; Ueda R; Chen G; Yu SZ; Tokudome S
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1241-8. PubMed ID: 9918433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
    Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
    Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.
    Wong DK; Yuen MF; Poon RT; Yuen JC; Fung J; Lai CL
    J Hepatol; 2006 Oct; 45(4):553-9. PubMed ID: 16904225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15.
    Yao Y; Li J; Lu Z; Tong A; Wang W; Su X; Zhou Y; Mu B; Zhou S; Li X; Chen L; Gou L; Song H; Yang J; Wei Y
    Electrophoresis; 2011 Aug; 32(15):2004-12. PubMed ID: 21739463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Real-time quantitation of hepatitis B virus (HBV) DNA in tumorous and surrounding tissue from patients with hepatocellular carcinoma.
    Zanella I; Rossini A; Domenighini D; Albertini A; Cariani E
    J Med Virol; 2002 Dec; 68(4):494-9. PubMed ID: 12376956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cells.
    Wu J; Zhang XJ; Shi KQ; Chen YP; Ren YF; Song YJ; Li G; Xue YF; Fang YX; Deng ZJ; Xu X; Gao J; Tang KF
    Carcinogenesis; 2014 Jan; 35(1):155-63. PubMed ID: 23917076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Susceptibility of Hep3B cells in different phases of cell cycle to tBid.
    Ma SH; Chen GG; Ye C; Leung BC; Ho RL; Lai PB
    Biochim Biophys Acta; 2011 Jan; 1813(1):179-85. PubMed ID: 20969896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic efficacy of improved α-fetoprotein promoter-mediated tBid delivered by folate-PEI600-cyclodextrin nanopolymer vector in hepatocellular carcinoma.
    Hu BG; Liu LP; Chen GG; Ye CG; Leung KK; Ho RL; Lin MC; Lai PB
    Exp Cell Res; 2014 Jun; 324(2):183-91. PubMed ID: 24726886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity.
    Pan W; Luo Q; Yan X; Yuan L; Yi H; Zhang L; Li B; Zhang Y; Sun J; Qiu MZ; Yang DJ
    Biochem Pharmacol; 2018 Aug; 154():127-135. PubMed ID: 29679556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low immunogenic bio-nanocapsule based on hepatitis B virus escape mutants.
    Jung J; Somiya M; Jeong SY; Choi EK; Kuroda S
    Nanomedicine; 2018 Feb; 14(2):595-600. PubMed ID: 29175598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HBsAg-specific CD8
    Hao X; Chen Y; Bai L; Wei H; Sun R; Tian Z
    Cell Mol Immunol; 2021 Jan; 18(1):128-137. PubMed ID: 31767976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Momordica charantia lectin exhibits antitumor activity towards hepatocellular carcinoma.
    Zhang CZ; Fang EF; Zhang HT; Liu LL; Yun JP
    Invest New Drugs; 2015 Feb; 33(1):1-11. PubMed ID: 25200916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma.
    Liu Q; Tian Y; Li Y; Zhang W; Cai W; Liu Y; Ren Y; Liang Z; Zhou P; Zhang Y; Bao Y; Li Y
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33323464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant hHscFv-RC-RNase protein derived from transgenic tobacco acts as a bifunctional molecular complex against hepatocellular carcinoma.
    Cui L; Peng H; Zhang R; Chen Y; Zhao L; Tang K
    Biotechnol Appl Biochem; 2012; 59(5):323-9. PubMed ID: 23586908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conjugates between monoclonal antibodies to HBsAg and cytosine arabinoside.
    Shouval D; Adler R; Wands JR; Hurwitz E
    J Hepatol; 1986; 3 Suppl 2():S87-95. PubMed ID: 3036937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of p53 with Bid induces cell death in response to etoposide treatment in hepatocellular carcinoma.
    Song G; Chen GG; Yun JP; Lai PB
    Curr Cancer Drug Targets; 2009 Nov; 9(7):871-80. PubMed ID: 20025574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.